Cinryze - Drug Insights, 2018
This report can be delivered to the clients within 24 hours
“Cinryze - Drug Insights, 2018” report by DelveInsight provides comprehensive information of the drug, Cinryze. It includes Cinryze`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Cinryze`s patents (US & EU). It also features the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also featured.
Depending on information availability
Overview of development activities around Cinryze
The segment comprises of detailed description of the product especially highlighting its regulatory milestones, research and development, deals & partnerships, patent and technology details.
Global Sales Assessment and analysis of market competition
Graphical representation of historical and forecasted global sales of Cinryze till 2022 and marked attention on the current market competition and upcoming emerging therapies in the same space.
METHODOLOGY
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
SCOPE OF THE REPORT
“Cinryze - Drug Insights, 2018” report by DelveInsight provides comprehensive information of the drug, Cinryze. It includes Cinryze`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Cinryze`s patents (US & EU). It also features the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also featured.
Depending on information availability
Overview of development activities around Cinryze
The segment comprises of detailed description of the product especially highlighting its regulatory milestones, research and development, deals & partnerships, patent and technology details.
Global Sales Assessment and analysis of market competition
Graphical representation of historical and forecasted global sales of Cinryze till 2022 and marked attention on the current market competition and upcoming emerging therapies in the same space.
METHODOLOGY
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
SCOPE OF THE REPORT
- A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
- Patent information around Cinryze in the United States (US) and Europe (EU) has been highlighted
- The report contains historical and forecasted sales for Cinryze till 2022
- Comprehensive coverage of the emerging therapies (Phase III) in the space where Cinryze operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
- The report also features the SWOT analysis of Cinryze
- Establish a comprehensive understanding of the drug, Cinryze
- Plan developmental timelines around Cinryze`s patents for the major markets- US and EU
- Understand Cinryze`s current and future growth through its historical and forecasted sales
- Identify and understand the current in-market competitors for Cinryze
- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
- Identify and plan ahead for prospective emerging players and their products operating in the same space as Cinryze
- Identify opportunities in the same area as Cinryze with DelveInsight`s SWOT analysis
Introduction
Cinryze - Overview
Product Description
Dosage and Strengths
Route of Synthesis
Mechanism of Action
Pharmacology
Pharmacodynamics
Pharmacokinetics
Adverse Reactions
Clinical Studies
Adolescent & Adult Study Results
Pediatric Study Results
Other Pipeline Activity
Regulatory Milestones
European Market Approval
United States Approval
Supplemental Biologics License Application (sBLA)
Acquisition
Technology
Designation
Agreement
Technology Transfer
Marketed Details
United States
Europe
Cinryze Sales Assessment
Global
Analyst Insights
Patent Details
Global API Manufacturers
India
Market Competitors
Emerging Therapies
SWOT Analysis
Appendix
Cinryze - Overview
Product Description
Dosage and Strengths
Route of Synthesis
Mechanism of Action
Pharmacology
Pharmacodynamics
Pharmacokinetics
Adverse Reactions
Clinical Studies
Adolescent & Adult Study Results
Pediatric Study Results
Other Pipeline Activity
Regulatory Milestones
European Market Approval
United States Approval
Supplemental Biologics License Application (sBLA)
Acquisition
Technology
Designation
Agreement
Technology Transfer
Marketed Details
United States
Europe
Cinryze Sales Assessment
Global
Analyst Insights
Patent Details
Global API Manufacturers
India
Market Competitors
Emerging Therapies
SWOT Analysis
Appendix
LIST OF TABLES
Table 1: Adverse reactions
Table 2: Cinryze, Marketed Details United States
Table 3: Cinryze, Marketed Details Europe
Table 4: Cinryze, Annual Global Sales from 2010-2022 (in million USD)
Table 5: Patent Details: Cinryze
Table 6: API Manufacturers for Complement C1 inhibitor protein
Table 7: API Manufacturers for Complement C1 inhibitor protein for India
Table 8: Market Competitors
Table 9: Emerging Therapies
Table 1: Adverse reactions
Table 2: Cinryze, Marketed Details United States
Table 3: Cinryze, Marketed Details Europe
Table 4: Cinryze, Annual Global Sales from 2010-2022 (in million USD)
Table 5: Patent Details: Cinryze
Table 6: API Manufacturers for Complement C1 inhibitor protein
Table 7: API Manufacturers for Complement C1 inhibitor protein for India
Table 8: Market Competitors
Table 9: Emerging Therapies
LIST OF FIGURES
Figure 1: Complement C1 esterase inhibitor Description
Figure 2: Cinryze, Annual Global Sales from 2010-2022 (in millions USD)
Figure 3: API Manufacturers for Complement C1 inhibitor protein
Figure 1: Complement C1 esterase inhibitor Description
Figure 2: Cinryze, Annual Global Sales from 2010-2022 (in millions USD)
Figure 3: API Manufacturers for Complement C1 inhibitor protein
